Maud A W Hermans
Overview
Explore the profile of Maud A W Hermans including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Veltman Y, Aalbers A, Hermans M, Mutsaers P
EJHaem
. 2025 Jan;
6(1):e1014.
PMID: 39866927
Introduction: Benralizumab is an interleukin 5-receptor-blocking drug registered for the treatment of eosinophilic asthma. It has proven efficient and safe in a small phase-II trial in hypereosinophilic syndrome and is...
2.
Vergouwen D, Hermans M, Sels L
Retin Cases Brief Rep
. 2023 Sep;
PMID: 37708470
Purpose: To report on an unexpected side effect of Rituximab (RTX), a B-cell targeting monoclonal agent, in a patient with severe sclerouveitis, leading to severe visual loss. Methods: Observational case...
3.
Damman J, Diercks G, van Doorn M, Pasmans S, Hermans M
Am J Dermatopathol
. 2023 Jun;
45(10):697-703.
PMID: 37378479
Mastocytosis is a condition characterized by accumulation of clonal mast cells (MCs) that often involves the skin. Pathologists are often challenged with skin biopsies with a question of cutaneous lesions...
4.
van der Aa L, van Egmond I, van der Sluijs M, den Otter A, Bosmans N, Van Beek S, et al.
Ther Adv Allergy Rhinol
. 2023 May;
14:27534030231172391.
PMID: 37207194
Background: Since the coronavirus pandemic in 2020, there is not much reported about the disease course of COVID-19 in patients with allergic diseases. Objectives: The aim of this study was...
5.
Kennedy V, Perkins C, Reiter A, Jawhar M, Lubke J, Kluin-Nelemans H, et al.
Blood Adv
. 2022 Sep;
7(9):1713-1724.
PMID: 36094848
Mast cell leukemia (MCL) is a rare subtype of systemic mastocytosis defined by ≥20% mast cells (MC) on a bone marrow aspirate. We evaluated 92 patients with MCL from the...
6.
Pyatilova P, Ashry T, Luo Y, He J, Bonnekoh H, Jiao Q, et al.
Front Immunol
. 2022 Aug;
13:930945.
PMID: 35958589
Background: Recently, the expression of the mast cell (MC) receptor Mas-related G protein-coupled receptor X2 (MRGPRX2) has been detected in lesional skin of adult patients with cutaneous mastocytosis. As of...
7.
Zondag T, Torralba-Raga L, van Laar J, Hermans M, Bouman A, Hollink I, et al.
J Clin Immunol
. 2022 Jul;
42(8):1685-1695.
PMID: 35870028
Autosomal recessive mutations in RAB27A are associated with Griscelli syndrome type 2 (GS2), characterized by hypopigmentation and development of early-onset, potentially fatal hemophagocytic lymphohistiocytosis (HLH). We describe a 35-year old...
8.
Hermans M, Pasmans S, Arends N, van den Bosch T, van Daele P, van Doorn M, et al.
Clin Exp Dermatol
. 2022 May;
47(9):1694-1702.
PMID: 35596520
Background: Mastocytosis is characterized by the accumulation of mast cells (MCs) in the skin or other organs, and can manifest at any age. A significant number of paediatric mastocytosis cases...
9.
van Daele P, Hermans M, Oude Elberink J, van Wijk R
Ned Tijdschr Geneeskd
. 2022 Feb;
166.
PMID: 35129899
Background: Idiopathic mast cell activation syndrome (MCAS) is one of the causes for recurrent complaints. The diagnosis is sometimes delayed but also often made incorrectly. Case: Our patient presented with...
10.
Hermans M, Heeringa J, Swagemakers S, Schrijver B, van Daele P, van der Spek P, et al.
J Allergy Clin Immunol
. 2022 Jan;
150(1):146-156.e10.
PMID: 35026208
Background: Indolent systemic mastocytosis (ISM) is characterized by pathologic accumulation of mast cells. The mechanism behind its phenotypic heterogeneity is not well understood. Interaction of mast cells with other immune...